Menu
Back to Journals » OncoTargets and Therapy » Volume 7
Original Research
Continuation of bevacizumab and addition of hormone therapy following weekly paclitaxel therapy in HER2-negative metastatic breast cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,918 | Dovepress* | 9,216+ | 1,094 | 10,310 | |
| PubMed Central* | 702 | 314 | 1,016 | ||
| Totals | 9,918 | 1,408 | 11,326 | ||
|
*Since 27 November 2014 +Since July 2016 |
|||||
View citations on PubMed Central and Google Scholar